SEC Comment Letter 0000000000-25-002812 to Vyome Holdings, Inc (HIND)

Vyome Holdings, Inc
Date: March 14, 2025 · CIK: 0001427570 · Accession: 0000000000-25-002812

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-37897

Date

March 14, 2025

Author

Finance

Form

UPLOAD

Company

Vyome Holdings, Inc

Letter

Re: ReShape Lifesciences Inc. Preliminary Proxy Statement on Schedule 14A Filed March 3, 2025 File No. 001-37897 Dear Paul Hickey:

March 14, 2025

Paul Hickey President and Chief Executive Officer ReShape Lifesciences Inc. 8 Technology Drive, Suite 110 Irvine, CA 92618

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: Brett Hanson, Esq.

Show Raw Text

<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 14, 2025

Paul Hickey
President and Chief Executive Officer
ReShape Lifesciences Inc.
8 Technology Drive, Suite 110
Irvine, CA 92618

 Re: ReShape Lifesciences Inc.
 Preliminary Proxy Statement on Schedule 14A
 Filed March 3, 2025
 File No. 001-37897
Dear Paul Hickey:

 We have completed our review of your filing. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
cc: Brett Hanson, Esq.
</TEXT>
</DOCUMENT>

SecProbe.io